RMR Wealth Builders’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

RMR Wealth Builders’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Buy	+10	New	+$8	﹤0.01%	424

Other funds holding GCVRZ

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

RMR Wealth Builders's GCVRZ Position: Q4 2019 in Review

RMR Wealth Builders opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q4 2019: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #424 among its holdings.

103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

RMR Wealth Builders held 10 shares of Sanofi Contingent Value Rights worth $0 as of Q4 2019.
Sanofi Contingent Value Rights was a new RMR Wealth Builders position in Q4 2019.
Sanofi Contingent Value Rights made up ﹤0.01% of RMR Wealth Builders's portfolio in Q4 2019, its #424 holding.
103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on RMR Wealth Builders's 13F filing for Q4 2019, filed 3 Mar 2020.